New regulation on the Eurasian Pharmaceutical Register

On the 7th of December, 2023 the Eurasian Patent Office (EAPO) has issued an official Regulation on the Eurasian Pharmaceutical Register (the EPR Register), which provides a list of international non-proprietary names of drugs and relevant Eurasian and national patents directed to:

– an active chemical compound under the INN,
– pharmaceutical compositions comprising the active compound,
– methods of preparing the active compound or compositions comprising thereof,
– medical uses of the compounds/compositions.
As for now the Register includes 226 INNs (and combinations of INN) and corresponding ca. 700 patents and is updated on a regular basis by the EAPO, which also provides the possibility for the patent owners to submit request for introducing patents into the register upon the patent office examination check.

Why this Register is important?
The establishment of the EPR Register is a further step to the creation of the transparent patent linkage system in the Eurasian region. In particular, it might be used by any interested parties including
– applicants of new drug applications,
– originator companies,
– drug registration authorities in the member states of the Eurasian Patent Convention including countries of the Eurasian Economic Union having unified drug registration rules,
– courts.
The Register is available online by the following link:
https://old.eapo.org/ru/patents/reestr/eafarma.php